HS is diagnosed using positive immunohistochemistry for histiocytic markers, such as CD68, CD4, CD163, or lysozyme, and can present in an isolated form or be associated with other hematologic malignancies, such as non-Hodgkin lymphoma (NHL) or acute leukemia (2–4). This evidence concerns the gene CD163 and non-Hodgkin lymphoma.